
Non-Animal Alternatives Testing Global Market Opportunities And Strategies To 2032
Description
Non-Animal Alternatives Testing Global Market Opportunities And Strategies To 2032
Including: 1) By Technology: Cell Culture Technology; High Throughput Technology; Molecular Imaging; Omics Technology2) By Method: Cellular Assay; Biochemical Assay; In Silico; Ex-Vivo3) By End-User: Pharmaceutical Industry; Cosmetics And Household Products; Diagnostics; Chemicals Industry; Food And Beverage IndustryCovering: Evotec SE (Cyprotex); Bio-Rad Laboratories, Inc; BioIVT; Emulate, Inc; MatTek Corporation"
Non-Animal Alternatives Testing Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global non-animal alternatives testing market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Where is the largest and fastest-growing market for non-animal alternatives testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The non-animal alternatives testing market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider non-animal alternatives testing market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics
- Key Trends
- Global Market Size and Growth
- Regional Analysis
- Market Segmentation
- Regional Market Size and Growth
- Competitive Landscape
- Key Mergers and Acquisitions
- Market Opportunities And Strategies
- Conclusions And Recommendations
- Appendix
Scope
Markets Covered:
1) By Technology: Cell Culture Technology; High Throughput Technology; Molecular Imaging; Omics Technology; Other Technologies
2) By Method: Cellular Assay; Biochemical Assay; In Silico; Ex-Vivo
3) By End-User: Pharmaceutical Industry; Cosmetics And Household Products; Diagnostics; Chemicals Industry; Food And Beverage Industry; Other End Users
Companies Mentioned: Evotec SE (Cyprotex); Bio-Rad Laboratories, Inc; BioIVT; Emulate, Inc; MatTek Corporation
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; non-animal alternatives testing indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
367 Pages
- 1. Executive Summary
- 2. Table Of Contents
- 3. List Of Figures
- 4. List Of Tables
- 5. Report Structure
- 6. Introduction And Market Characteristics
- 6.1. General Market Definition
- 6.2. Summary
- 6.3. Non-Animal Alternatives Testing Market Definition And Segmentations
- 6.4. Market Segmentation By Technology
- 6.4.1. Cell Culture Technology
- 6.4.2. High Throughput Technology
- 6.4.3. Molecular Imaging
- 6.4.4. Omics Technology
- 6.4.5. Other Technologies
- 6.5. Market Segmentation By Method
- 6.5.1. Cellular Assay
- 6.5.2. Biochemical Assay
- 6.5.3. In Silico
- 6.5.4. Ex-Vivo
- 6.6. Market Segmentation By End-User
- 6.6.1. Pharmaceutical Industry
- 6.6.2. Cosmetics And Household Products
- 6.6.3. Diagnostics
- 6.6.4. Chemicals Industry
- 6.6.5. Food And Beverage Industry
- 6.6.6. Other End-Users
- 7. Major Market Trends
- 7.1. Developments In OOC (Organ-On-Chip) For Testing
- 7.2. Adoption Of In Silico Trials
- 7.3. Use Of Model Organisms
- 7.4. Focus On 3D-Printed Organs For Testing
- 7.5. Increasing Collaborations And Partnerships To Reduce Animal Testing
- 7.6. Rising Initiatives And Grants To Promote Animal-Free Testing
- 8. Global Market Size and Growth
- 8.1. Market Size
- 8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
- 8.2.1. Market Drivers 2017 – 2022
- 8.2.2. Market Restraints 2017 – 2022
- 8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 8.3.1. Market Drivers 2022 – 2027
- 8.3.2. Market Restraints 2022 – 2027
- 9. Global Non-Animal Alternatives Testing Market Segmentation
- 9.1. Global Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 9.2. Global Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 9.3. Global Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 10. Non-Animal Alternatives Testing Market, Regional and Country Analysis
- 10.1. Global Non-Animal Alternatives Testing Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 10.2. Global Non-Animal Alternatives Testing Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11. Asia-Pacific Market
- 11.1. Summary
- 11.2. Market Overview
- 11.2.1. Region Information
- 11.2.2. Market Information
- 11.2.3. Background Information
- 11.2.4. Government Initiatives
- 11.2.5. Regulations
- 11.2.6. Regulatory Bodies
- 11.2.7. Major Associations
- 11.2.8. Taxes Levied
- 11.2.9. Corporate Tax Structure
- 11.2.10. Investments
- 11.2.11. Major Companies
- 11.3. Asia-Pacific Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 11.4. Asia-Pacific Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 11.5. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.6. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.7. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.8. Asia-Pacific Non-Animal Alternatives Testing Market: Country Analysis
- 11.9. China Market
- 11.10. Summary
- 11.11. Market Overview
- 11.11.1. Country Information
- 11.11.2. Market Information
- 11.11.3. Background Information
- 11.11.4. Government Initiatives
- 11.11.5. Regulations
- 11.11.6. Regulatory Bodies
- 11.11.7. Major Associations
- 11.11.8. Taxes Levied
- 11.11.9. Corporate tax structure
- 11.11.10. Investments
- 11.11.11. Major Companies
- 11.12. China Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 11.13. China Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 11.14. China Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.15. China Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.16. China Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.17. India Market
- 11.18. India Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 11.19. India Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 11.20. India Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.21. India Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.22. India Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.23. Japan Market
- 11.24. Japan Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 11.25. Japan Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 11.26. Japan Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.27. Japan Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.28. Japan Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.29. Australia Market
- 11.30. Australia Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 11.31. Australia Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 11.32. Australia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.33. Australia Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.34. Australia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.35. Indonesia Market
- 11.36. Indonesia Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 11.37. Indonesia Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 11.38. Indonesia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.39. Indonesia Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.40. Indonesia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.41. South Korea Market
- 11.42. South Korea Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 11.43. South Korea Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 11.44. South Korea Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.45. South Korea Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 11.46. South Korea Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 12. Western Europe Market
- 12.1. Summary
- 12.2. Market Overview
- 12.2.1. Region Information
- 12.2.2. Market Information
- 12.2.3. Background Information
- 12.2.4. Government Initiatives
- 12.2.5. Regulations
- 12.2.6. Regulatory Bodies
- 12.2.7. Major Associations
- 12.2.8. Taxes Levied
- 12.2.9. Corporate Tax Structure
- 12.2.10. Investments
- 12.2.11. Major Companies
- 12.3. Western Europe Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 12.4. Western Europe Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 12.5. Western Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 12.6. Western Europe Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 12.7. Western Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 12.8. Western Europe Non-Animal Alternatives Testing Market: Country Analysis
- 12.9. UK Market
- 12.10. UK Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 12.11. UK Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 12.12. UK Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 12.13. UK Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 12.14. UK Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 12.15. Germany Market
- 12.16. Germany Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 12.17. Germany Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 12.18. Germany Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 12.19. Germany Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 12.20. Germany Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 12.21. France Market
- 12.22. France Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 12.23. France Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 12.24. France Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 12.25. France Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 12.26. France Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 13. Eastern Europe Market
- 13.1. Summary
- 13.2. Market Overview
- 13.2.1. Region Information
- 13.2.2. Market Information
- 13.2.3. Background Information
- 13.2.4. Government Initiatives
- 13.2.5. Regulations
- 13.2.6. Regulatory Bodies
- 13.2.7. Major Associations
- 13.2.8. Taxes Levied
- 13.2.9. Corporate Tax Structure
- 13.2.10. Investments
- 13.2.11. Major Companies
- 13.3. Eastern Europe Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 13.4. Eastern Europe Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 13.5. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 13.6. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 13.7. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 13.8. Eastern Europe Non-Animal Alternatives Testing Market: Country Analysis
- 13.9. Russia Market
- 13.10. Russia Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 13.11. Russia Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 13.12. Russia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 13.13. Russia Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 13.14. Russia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 14. North America Market
- 14.1. Summary
- 14.2. Market Overview
- 14.2.1. Region Information
- 14.2.2. Market Information
- 14.2.3. Background Information
- 14.2.4. Government Initiatives
- 14.2.5. Regulations
- 14.2.6. Regulatory Bodies
- 14.2.7. Major Associations
- 14.2.8. Taxes Levied
- 14.2.9. Corporate Tax Structure
- 14.2.10. Investments
- 14.2.11. Major Companies
- 14.3. North America Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 14.4. North America Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 14.5. North America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 14.6. North America Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 14.7. North America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 14.8. North America Non-Animal Alternatives Testing Market: Country Analysis
- 14.9. USA Market
- 14.10. Summary
- 14.11. Market Overview
- 14.11.1. Country Information
- 14.11.2. Market Information
- 14.11.3. Background Information
- 14.11.4. Government Initiatives
- 14.11.5. Regulations
- 14.11.6. Regulatory Bodies
- 14.11.7. Major Associations
- 14.11.8. Taxes Levied
- 14.11.9. Corporate Tax Structure
- 14.11.10. Investments
- 14.11.11. Major Companies
- 14.12. USA Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 14.13. USA Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 14.14. USA Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 14.15. USA Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 14.16. USA Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 15. South America Market
- 15.1. Summary
- 15.2. Market Overview
- 15.2.1. Region Information
- 15.2.2. Market Information
- 15.2.3. Background Information
- 15.2.4. Government Initiatives
- 15.2.5. Regulations
- 15.2.6. Regulatory Bodies
- 15.2.7. Major Associations
- 15.2.8. Taxes Levied
- 15.2.9. Corporate Tax Structure
- 15.2.10. Major Companies
- 15.3. South America Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 15.4. South America Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 15.5. South America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 15.6. South America Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 15.7. South America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 15.8. South America Non-Animal Alternatives Testing Market: Country Analysis
- 15.9. Brazil Market
- 15.10. Brazil Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 15.11. Brazil Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 15.12. Brazil Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 15.13. Brazil Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 15.14. Brazil Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 16. Middle East Market
- 16.1. Summary
- 16.2. Market Overview
- 16.2.1. Region Information
- 16.2.2. Market Information
- 16.2.3. Background Information
- 16.2.4. Government Initiatives
- 16.2.5. Regulations
- 16.2.6. Regulatory Bodies
- 16.2.7. Major Associations
- 16.2.8. Taxes Levied
- 16.2.9. Corporate Tax Structure
- 16.2.10. Investments
- 16.2.11. Major Companies
- 16.3. Middle East Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 16.4. Middle East Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 16.5. Middle East Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 16.6. Middle East Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 16.7. Middle East Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 17. Africa Market
- 17.1. Summary
- 17.2. Market Overview
- 17.2.1. Region Information
- 17.2.2. Market Information
- 17.2.3. Background Information
- 17.2.4. Government Initiatives
- 17.2.5. Regulations
- 17.2.6. Regulatory Bodies
- 17.2.7. Major Associations
- 17.2.8. Taxes Levied
- 17.2.9. Corporate Tax Structure
- 17.2.10. Major Companies
- 17.3. Africa Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
- 17.4. Africa Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
- 17.5. Africa Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 17.6. Africa Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 17.7. Africa Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
- 18. Competitive Landscape and Company Profiles
- 19. Company Profiles
- 19.1. Evotec SE
- 19.1.1. Company Overview
- 19.1.2. Products And Services
- 19.1.3. Business Strategy
- 19.1.4. Financial Overview
- 19.2. Bio-Rad Laboratories Inc
- 19.2.1. Company Overview
- 19.2.2. Products And Services
- 19.2.3. Business Strategy
- 19.2.4. Financial Overview
- 19.3. BioIVT
- 19.3.1. Company Overview
- 19.3.2. Products And Services
- 19.3.3. Business Strategy
- 19.3.4. Financial Overview
- 19.4. Emulate, Inc
- 19.4.1. Company Overview
- 19.4.2. Products And Services
- 19.4.3. Business Strategy
- 19.4.4. Financial Overview
- 19.5. MatTek Corporation
- 19.5.1. Company Overview
- 19.5.2. Products And Services
- 19.5.3. Business Strategy
- 19.5.4. Financial Overview
- 20. Key Mergers And Acquisitions
- 20.1. AnaBios Acquired Cell Systems
- 20.2. Molecular Devices LLC Acquired Cellesce Ltd.
- 20.3. Angus Chemical Company Acquired Expression Systems
- 20.4. Cytiva Acquired CEVEC Pharmaceuticals
- 20.5. Evotec Acquired Rigenerand
- 20.6. SenzaGen Acquired VitroScreen S.r.l.
- 20.7. Bico Group Acquired HUREL Micro Liver Technologies
- 20.8. Bruker Acquired Canopy Biosciences, LLC
- 20.9. Sartorius Acquired Xell AG
- 20.10. Bio-Techne Acquired Asuragen Inc.
- 20.11. PerkinElmer Acquired Immunodiagnostic Systems Holdings PLC
- 20.12. Agilent Acquired Resolution Bioscience
- 20.13. Certara Acquired Silico Biosciences Inc.
- 21. Opportunities And Strategies
- 21.1. Global Non-Animal Alternatives Testing Market In 2027 – Countries Offering Most New Opportunities
- 21.2. Global Non-Animal Alternatives Testing Market In 2027 – Segments Offering Most New Opportunities
- 21.3. Global Non-Animal Alternatives Testing Market In 2027 – Growth Strategies
- 21.3.1. Market Trend Based Strategies
- 21.3.2. Competitor Strategies
- 22. Non-Animal Alternatives Testing Market, Conclusions And Recommendations
- 22.1. Conclusions
- 22.2. Recommendations
- 22.2.1. Product
- 22.2.2. Place
- 22.2.3. Price
- 22.2.4. Promotion
- 22.2.5. People
- 23. Appendix
- 23.1. Market Data Sources
- 23.2. Research Methodology
- 23.3. Currencies
- 23.4. The Business Research Company
- 23.5. Copyright and Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.